TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17983841

Group type: EXPERIMENTAL
Intervention: PEMF stimulation after surgery (PEMF group, 163 patients)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Control group (160 patients)
Number of subjects: 323
Study: 16537857

Group type: EXPERIMENTAL
Intervention: Bronchial hyperresponsiveness (BHR) determined by methacholine challenge test with a provocative concentration producing a 20% fall in FEV(1) < or = 8 mg/mL.
Number of subjects: 3454

Group type: EXPERIMENTAL
Intervention: Definite asthma defined as BHR present with any asthma symptom within the past 12 months or demonstrated reversible airflow obstruction.
Number of subjects: 3454

Group type: EXPERIMENTAL
Intervention: Current diagnosed asthma defined as previous physician‐diagnosed asthma and any asthma symptom within the past 12 months or currently receiving asthma medication.
Number of subjects: 3454
Study: 14678209

Group type: EXPERIMENTAL
Intervention: Patch testing with hydroxycitronellal plus sodium lauryl sulfate (SLS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Patch testing with hydroxycitronellal alone
Number of subjects: 20
Study: 10802474

Group type: EXPERIMENTAL
Intervention: Antibiotic solution of neomycin and polymyxin B
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 10% providone‐iodine solution
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate solution
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (untreated dropped grafts)
Number of subjects: 50
Study: 8829861

Group type: EXPERIMENTAL
Intervention: EMLA
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: COMPARATOR
Intervention: Reference puncture (no anaesthesia)
Number of subjects: 26
Study: 1735845

Group type: EXPERIMENTAL
Intervention: Synthetic surfactant (Exosurf Neonatal)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Air placebo
Number of subjects: 2
Study: 6428917

Group type: EXPERIMENTAL
Intervention: Gliquidone (Glurenorm)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 20
Study: 30724455

Group type: EXPERIMENTAL
Intervention: Lorcaserin treatment
Number of subjects: 48
Study: 27733650

Group type: COMPARATOR
Intervention: Therapeutic exercises only (Group 1)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Kinesiology taping on the affected side with inhibition technique plus therapeutic exercises (Group 2)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Kinesiology taping on the unaffected side with facilitation technique and on the affected side with inhibition technique plus therapeutic exercises (Group 3)
Number of subjects: 33
Study: 25943466

Group type: EXPERIMENTAL
Intervention: Home BP/PP variability parameters
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Low frequency (LF) power of beat‐to‐beat BP/PP variability
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: PP variability parameters
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Home HR variability parameters
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 24‐h hour‐to‐hour HR variability
Number of subjects: 150
Study: 24400953

Group type: COMPARATOR
Intervention: 4 mg intravenous dexamethasone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 6 mg oral dexamethasone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Comparison of 6 mg oral vs. 4 mg intravenous dexamethasone
Number of subjects: 30
Study: 22928400

Group type: EXPERIMENTAL
Intervention: Multidisciplinary program (MP), n = 86
Number of subjects: 173

Group type: COMPARATOR
Intervention: Usual care (UC), n = 87
Number of subjects: 173
Study: 19002481

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A injection (2-5 IU in 0.2-0.5 ml of saline)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 17729055

Group type: EXPERIMENTAL
Intervention: Psyllium powder 3.5 gr t.i.d.
Number of subjects: 141

Group type: COMPARATOR
Intervention: Guar gum 3.5 gr t.i.d.
Number of subjects: 141

Group type: COMPARATOR
Intervention: Standard diet
Number of subjects: 141
Study: 15535166

Group type: EXPERIMENTAL
Intervention: Patients with orbital prefrontal cortex damage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 0
Study: 10770543

Group type: EXPERIMENTAL
Intervention: RTV/SQV
Number of subjects: 208

Group type: COMPARATOR
Intervention: RTV/SQV/D4T
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Intensified treatment
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 208
Study: 9307249

Group type: EXPERIMENTAL
Intervention: Unilateral high-frequency stimulation of the ventral intermedius nucleus of the thalamus
Number of subjects: 53
Study: 8340603

Group type: EXPERIMENTAL
Intervention: Recombinant human alpha 2A interferon (6 million units three times per week for 6 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Recombinant human alpha 2A interferon
Number of subjects: 40
Study: 3552659

Group type: EXPERIMENTAL
Intervention: B-mode ultrasound
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Halved skinfold
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: A-mode ultrasound
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Skinfold calipers
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Correlation between protocols for men
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Correlation between protocols for women
Number of subjects: 42
Study: 30285891

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for IBS
Number of subjects: 600

Group type: COMPARATOR
Intervention: Western medicine treatment for IBS
Number of subjects: 600
Study: 25862026

Group type: EXPERIMENTAL
Intervention: Self-gripping mesh repair
Number of subjects: 507

Group type: COMPARATOR
Intervention: Lichtenstein repair with suture fixation
Number of subjects: 507
Study: 27845635

Group type: EXPERIMENTAL
Intervention: 6 months of daily isoniazid preventive therapy (IPT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 82
Study: 22440275

Group type: EXPERIMENTAL
Intervention: VEGF Trap‐Eye 2 mg
Number of subjects: 189

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 189
Study: 20551734

Group type: EXPERIMENTAL
Intervention: Evidence-based intervention protocol for emotional support
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual standard of care
Number of subjects: 40
Study: 18700371

Group type: EXPERIMENTAL
Intervention: Immediate loading protocol (loaded within 24 hours of surgery)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Delayed loading protocol (connected to a healing abutment and restored after 3 to 4 months)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Immediate loading protocol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Delayed loading protocol
Number of subjects: 30
Study: 15970844

Group type: EXPERIMENTAL
Intervention: Low-dose hCG (200 IU intramuscular injection daily) after 100 mg CC
Number of subjects: 67

Group type: COMPARATOR
Intervention: 150 mg CC
Number of subjects: 67
Study: 12890761

Group type: EXPERIMENTAL
Intervention: BDNF val66met genotype (met carriers)
Number of subjects: 0

Group type: COMPARATOR
Intervention: BDNF val66met genotype (val homozygotes)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interaction between BDNF val66met genotype and hippocampal response during encoding
Number of subjects: 0
Study: 11026416

Group type: EXPERIMENTAL
Intervention: Drawing of the sun on the bottom of customers' checks
Number of subjects: 0

Group type: COMPARATOR
Intervention: No drawing on the bottom of customers' checks
Number of subjects: 0
Study: 9004107

Group type: COMPARATOR
Intervention: Trandolapril 2 mg and placebo
Number of subjects: 23

Group type: COMPARATOR
Intervention: Trandolapril 2 mg and indomethacin
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Indomethacin and placebo
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Placebo and placebo
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Trandolapril 2 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 23
Study: 1857525

Group type: EXPERIMENTAL
Intervention: Cyclosporin with blood transfusions (group 1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Blood transfusions alone (group 2)
Number of subjects: 24
Study: 6863470

Group type: EXPERIMENTAL
Intervention: Cholestyramine
Number of subjects: 3810

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3810
Study: 31076823

Group type: EXPERIMENTAL
Intervention: Catheter-based left atrial appendage closure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ongoing randomized studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CLOSURE AF trial
Number of subjects: 0
Study: 29095516

Group type: EXPERIMENTAL
Intervention: Vesair balloon placement
Number of subjects: 221

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 221
Study: 26037274

Group type: EXPERIMENTAL
Intervention: 30% silver diammine fluoride (SDF) solution applied every 12 months
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: 30% silver diammine fluoride (SDF) solution applied three times at weekly intervals at baseline
Number of subjects: 304

Group type: COMPARATOR
Intervention: 5% sodium fluoride (NaF) varnish applied three times at weekly intervals at baseline
Number of subjects: 304
Study: 24930428

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (2000 units)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (4000 units)
Number of subjects: 104
Study: 22328464

Group type: EXPERIMENTAL
Intervention: Ropinirole
Number of subjects: 404

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 404
Study: 20627222

Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 2305

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2305
Study: 17586783

Group type: EXPERIMENTAL
Intervention: Escitalopram (10 or 20 mg per day)
Number of subjects: 405

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 405
Study: 16238765

Group type: EXPERIMENTAL
Intervention: Discharge planning intervention
Number of subjects: 126

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 126
Study: 12127180

Group type: EXPERIMENTAL
Intervention: Behavioral treatment of insomnia
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: SDB treatment (either nasal CPAP or nasal turbinates)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Delayed treatment of insomnia (10 sleep hygiene recommendations)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: SDB treatment (nasal CPAP or nasal turbinates)
Number of subjects: 130
Study: 10388231

Group type: EXPERIMENTAL
Intervention: Lymphocyte predominance (LP) pattern observed in lymph nodes of breast and stomach carcinomas; significant association with stage and grade of disease in breast carcinoma.
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Histological patterns classified as lymphocyte predominance (LP), germinal centre predominance (GCP), lymphocyte depletion (LD), and unstimulated (U).
Number of subjects: 64
Study: 8569816

Group type: EXPERIMENTAL
Intervention: Flutrimazole 1% solution, applied once daily for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bifonazole 1% solution, applied once daily for 4 weeks
Number of subjects: 40
Study: 2357865

Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride 0.5 mg/hr
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride 1 mg/hr
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride 2 mg/hr
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride 4 mg/hr
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride 5 mg/hr
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride 8 mg/hr
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride 2 mg/hr (severe hypertension)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 6274571

Group type: EXPERIMENTAL
Intervention: ACTH (10 i.u./day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham infusions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrocortisone infusions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol or indomethacin (additional treatment)
Number of subjects: 0
Study: 30979038

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum PS128 (PS128)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29251954

Group type: EXPERIMENTAL
Intervention: Internet-based affect-focused psychodynamic therapy (IPDT) for 10 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 72
Study: 27454410

Group type: EXPERIMENTAL
Intervention: Facilitated Integrated Mood Management (FIMM); 5 therapist-facilitated psychoeducation sessions.
Number of subjects: 121

Group type: COMPARATOR
Intervention: Manualized Integrated Mood Management (MIMM); self-administered psychoeducation.
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Both FIMM and MIMM interventions.
Number of subjects: 121
Study: 24389933

Group type: EXPERIMENTAL
Intervention: Denervation of the patella
Number of subjects: 71

Group type: COMPARATOR
Intervention: No denervation of the patella
Number of subjects: 71
Study: 22467107

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin administration (16 IU)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 19440519

Group type: EXPERIMENTAL
Intervention: Intervention schools
Number of subjects: 4763

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 4763

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 4763

Group type: EXPERIMENTAL
Intervention: Both genders
Number of subjects: 4763
Study: 17314587

Group type: EXPERIMENTAL
Intervention: SSRIs (paroxetine or citalopram)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Gabapentin
Number of subjects: 101
Study: 17179461

Group type: EXPERIMENTAL
Intervention: ICD programming techniques
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic medications
Number of subjects: 0

Group type: COMPARATOR
Intervention: ICD shocks (both appropriate and inappropriate)
Number of subjects: 0
Study: 14710804

Group type: EXPERIMENTAL
Intervention: Home-based exercise therapy
Number of subjects: 24
Study: 10390212

Group type: EXPERIMENTAL
Intervention: Zanamivir (600 mg) intravenously twice daily for 5 days
Number of subjects: 0
Study: 8664019

Group type: EXPERIMENTAL
Intervention: Antegrade cold blood cardioplegia
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Retrograde cold blood cardioplegia
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Coronary sinus occlusion during antegrade supply
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Patients with major vessel disease and reduced left ventricular function
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Patients with aortic cross-clamp times of more than 1 h
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Patients with myocardial temperature of 22 +/- 3 degrees C before terminal cardioplegia
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Elevated myoglobin peaks within 1 h after aortic declamping
Number of subjects: 62
Study: 1799889

Group type: EXPERIMENTAL
Intervention: Benazepril 10 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Benazepril 20 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 6365208

Group type: EXPERIMENTAL
Intervention: PF therapy (1-phenylalanine mustard and 5-fluorouracil)
Number of subjects: 0
Study: 28114735

Group type: COMPARATOR
Intervention: Carvedilol (25 mg oral single dose) with glibenclamide (5 mg) and metformin (500 mg)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Carvedilol (25 mg oral single dose) in type 2 diabetes mellitus patients
Number of subjects: 26
Study: 26114297

Group type: EXPERIMENTAL
Intervention: Universal vaccination with one dose of 23-valent pneumococcal polysaccharide vaccine (PPV23)
Number of subjects: 7810

Group type: COMPARATOR
Intervention: Current practice (vaccination of institutionalized elderly and elderly with underlying diseases)
Number of subjects: 7810
Study: 23052228

Group type: EXPERIMENTAL
Intervention: zoledronate 5 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 22
Study: 20497640

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) + inhaled corticosteroids (ICS)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Inhaled corticosteroids (ICS) alone
Number of subjects: 32
Study: 18924528

Group type: EXPERIMENTAL
Intervention: Faustlos violence prevention program
Number of subjects: 13
Study: 16422223

Group type: EXPERIMENTAL
Intervention: Non‐Contact Tonometer (NCT)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Pascal Dynamic Contour Tonometer (DCT)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Central Corneal Thickness (CCT)
Number of subjects: 352
Study: 12591753

Group type: EXPERIMENTAL
Intervention: LQT1 during exercise stress test
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: LQT2 during exercise stress test
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 82
Study: 10363395

Group type: EXPERIMENTAL
Intervention: Functional stabilization (elastic adhesive bandaging for 7 days without support)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Orthopedic stabilization (subsequent ferule for 21 days)
Number of subjects: 80
Study: 8905424

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 72 mg/kg i.v. as a bolus, later 72 mg/kg over 12 h
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (no premedication)
Number of subjects: 18
Study: 1867454

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 50, 200, or 800 micrograms twice daily for 4 weeks
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 6347382

Group type: EXPERIMENTAL
Intervention: Clotrimazole (1%) vaginal cream for seven days
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Miconazole (2%) vaginal cream for seven days
Number of subjects: 93

Group type: COMPARATOR
Intervention: Clotrimazole (1%) vaginal cream
Number of subjects: 93

Group type: COMPARATOR
Intervention: Miconazole (2%) vaginal cream
Number of subjects: 93

Group type: COMPARATOR
Intervention: Oral contraceptive use
Number of subjects: 93
Study: 31466807

Group type: EXPERIMENTAL
Intervention: Caregiving self‐management support program (six bi‐weekly social support group sessions)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Telephone instructions (three monthly instructions)
Number of subjects: 41
Study: 31576437

Group type: EXPERIMENTAL
Intervention: Na154 (154 mmol/L sodium)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Na54 (54 mmol/L sodium)
Number of subjects: 70
Study: 28372526

Group type: EXPERIMENTAL
Intervention: Adjunctive metformin (n=253)
Number of subjects: 509

Group type: COMPARATOR
Intervention: Control group (n=256)
Number of subjects: 509
Study: 25525759

Group type: EXPERIMENTAL
Intervention: Nanorap (topical application of 2 g)
Number of subjects: 0
Study: 24295006

Group type: EXPERIMENTAL
Intervention: Conventional steel bur
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Chemomechanical method
Number of subjects: 30
Study: 21224335

Group type: EXPERIMENTAL
Intervention: Thin Physique Salient (TPS) video
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Thin Physique Non-Salient (TPNS) video
Number of subjects: 99
Study: 19763753

Group type: EXPERIMENTAL
Intervention: Bandage contact lens with an 8.8-mm base curve
Number of subjects: 27

Group type: COMPARATOR
Intervention: Bandage contact lens with an 8.4-mm base curve
Number of subjects: 27
Study: 17826453

Group type: EXPERIMENTAL
Intervention: Sensory retraining of the more affected lower limb
Number of subjects: 21

Group type: COMPARATOR
Intervention: Relaxation (sham intervention)
Number of subjects: 21
Study: 15497366

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg x kg(‐1) body mass, initial dose)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Caffeine (2.5 mg x kg(‐1) body mass, re-dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 10678627

Group type: EXPERIMENTAL
Intervention: Weight training (12 week hospital outpatient programme)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no weight training)
Number of subjects: 43
Study: 9083710

Group type: EXPERIMENTAL
Intervention: Famotidine (20-mg wafer)
Number of subjects: 829

Group type: COMPARATOR
Intervention: Ranitidine (150-mg tablet)
Number of subjects: 829
Study: 1443471

Group type: EXPERIMENTAL
Intervention: Group A - statements about common facts of some years ago
Number of subjects: 43

Group type: COMPARATOR
Intervention: Group B - new verbal associations, i.e. names of fictitious, nonfamous people
Number of subjects: 43
Study: 3574641

Group type: EXPERIMENTAL
Intervention: Ketanserin 20 mg twice daily for 6 days
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Ketanserin 20 mg for 2 weeks followed by 40 mg for 3 weeks
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 31116186

Group type: EXPERIMENTAL
Intervention: 5-mm short implants
Number of subjects: 30

Group type: COMPARATOR
Intervention: 10-mm long implants
Number of subjects: 30
Study: 28616919

Group type: EXPERIMENTAL
Intervention: Early postoperative enteral immune nutrition for 7 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal nutrition
Number of subjects: 60
Study: 26438161

Group type: EXPERIMENTAL
Intervention: Anakinra (recombinant human interleukin‐1 receptor antagonist)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 22946890

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate (DE) 150 mg alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate (DE) 150 mg with verapamil 120 mg immediate release given 1 hour before DE
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate (DE) 150 mg with verapamil 240 mg extended release
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate (DE) 150 mg after multiple verapamil dosing
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate (DE) 150 mg given 2 hours before verapamil
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate (DE) with verapamil
Number of subjects: 40